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Summary
The 
Introduction
Though migraine and tension-type headache are extralasting primary headaches are important to recognize because of their excellent but highly selective response to treatment. ordinarily common, some primary headache syndromes are relatively rare and poorly recognized in mainstream neuroAccurate diagnosis will often lead to appropriate treatment and the rapid relief of the patient's pain problem. It is also logical practice. Despite the diagnostic challenges, the short- 
Chronic paroxysmal hemicrania (CPH)
shortlasting unilateral neuralgiform headache with conjunctival CPH, a relatively well-characterized disorder (Russell, 1984;  injection and tearing. Antonaci and Sjaastad, 1989; Sjaastad and Shen, 1991; Spierings, 1992) , was first described in 1974 possible that some of these syndromes are not as rare as (Sjaastad and Dale, 1974; Sjaastad, 1986) and appears in currently believed. Finally, the curious associated features the International Headache Society classification (Headache of these disorders may help us to understand better the Classification Committee of the IHS, 1988) . The condition mechanisms of the more common primary headaches.
is defined by operational diagnostic criteria including frequent In this article, we discuss a group of primary headache short-lasting attacks of unilateral pain, usually in the orbital, disorders characterized by short-lived unilateral pain and supra-orbital or temporal region that last 2-45 min. The ipsilateral autonomic features. A more comprehensive list of characteristic attack frequency is ജ5 per day, but there are short-lasting headaches is provided in Table 1 . Idiopathic literature reports of between 1 and 40 attacks per day. The stabbing headache, cough headache, exertional headache, pain is associated with at least one autonomic symptom sexual headache and trigeminal neuralgia are not reviewed such as conjunctival injection, lacrimation, nasal congestion, as these disorders have no autonomic component. Cluster rhinorrhoea, ptosis or eyelid oedema. The IHS criteria require headache (Kudrow, 1980; Lance, 1993) and that the attacks should rapidly resolve following treatment its treatment is extensively reviewed elsewhere (Goadsby, with indomethacin. The dose is up to 150 mg/day orally and 1994). We hypothesize that the short-lasting headaches with the response is usually within days of initiating an adequate autonomic features are characterized by a nexus of activation dose. The IHS diagnostic criteria have proved to be very between trigeminal afferents (giving rise to pain) and cranial reliable in their practical application in CPH (Leone et al., parasympathetic efferents (giving rise to autonomic features), 1994) . Although the attack frequency may vary, by definition, a trigeminal-autonomic activation. A linked pathophysiology the chronic forrn should not remit. The IHS classification is the hallmark of these syndromes which we shall term noted that 'the chronic stage may be preceded by an episodic trigeminal-autonomic cephalgias (TACs), connecting their stage similar to the pattern seen in cluster headache, but this clinical phenotype but not necessarily implying a common
has not yet been sufficiently validated'. underlying pathogenesis. Given that all head pain involves
The relationship between CPH and cluster headache is trigeminal afferent activity, and that trigeminal-autonomic uncertain. The many clinical similarities between cluster connections are likely to be present and functional (Goadsby headache and chronic paroxysmal hemicrania argue that the and Lance, 1988) , it is a peculiarity of these syndromes that disorders should be broadly classified together. CPH is there is relatively marked cranial parasympathetic outflow.
distinguished from cluster headache primarily by the shorter Some short-lived headaches have serious underlying duration and higher frequency of headache attacks, by the causes. Structural disease may give rise to short-lived female preponderance of the disorder and by the selective headaches sometimes triggered by a Valsalva or postural response to indomethacin. As cases have emerged (Price and change. Mass lesions, including those which interfere with Posner, 1978; Russell et al., 1978; Hochman, 1981 ; Rapoport cerebrospinal fluid egress, and pathology in the posterior et al., 1981) the clinical boundaries have become somewhat fossa or base of the skull are particularly associated with shortless distinct. It seems inappropriate at a biological level, and lived Valsalva or cough-related headache. Even subarachnoid perhaps a clinical level, to insist on the absolute response to haemorrhage can give rise to brief headache. These secondary indomethacin as a diagnostic indicator. This would be better headaches are outside the scope of the present discussion reduced to a strong indicator to the diagnosis until the and have been reviewed recently (Edmeads, 1997) .
biological basis for that response is better understood. We review here the clinical features, laboratory investigations and pathophysiology of the TACs including chronic paroxysmal hemicrania (CPH), episodic paroxysmal hemi-
Clinical features
CPH has no racial boundaries and is well described in black crania (EPH) and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT). We South Africans (Joubert et al., 1987; Joubert, 1988) . The age of onset is usually in the twenties (Sjaastad, 1986) , although disorder to study. The available observations suggest similarities with cluster headache. there have also been reports of the condition in children at the ages of 3 (Broeske et al., 1993) , 9 (Kudrow and Kudrow, 1989 ) and 8 years (Gladstein et al., 1994) . At least one of Blood and neuropeptide changes. Alterations in cylic release of catecholamines and β-endorphin are observed in these cases (Gladstein et al., 1994) may be better characterized as a cluster headache (Solomon and Newman, 1995) . In CPH (Micieli et al., 1989) , and are similar to those reported in cluster headache. Recently, we observed an increased paediatric cases, the syndrome may be characterized by daily attacks. The natural history will ultimately be determined by level of calcitonin-gene related peptide (CGRP) and VIP in the cranial venous blood of a patient with CPH. The levels long-term observations. The sex distribution is a 3:1 female to male ratio (Antonaci and Sjaastad, 1989) . Although the returned to normal with successful treatment using indomethacin . These data pain is usually in the distribution of the ophthalmic division of the trigeminal nerve, it has been reported in the occipital are discussed in the section 'Pathophysiology of TACS' below. Other observations in CPH include relative thromboregion in a single case (Sjaastad, 1986) . Although occipital pain may seem curious on anatomical grounds, this clinical cythaemia (MacMillan and Nukada, 1989 ) and increased phosphatidylserine labelling in neutrophils (Fragoso et al., finding has an experimental correlate. In animal experiments, stimulation of the greater occipital nerve leads to release of 1988). The relationship of these changes to the underlying problem is not clear. Blood dyscrasias would not be a vasoactive peptides, such as vasoactive intestinal polypeptide (VIP) (Vincent et al., 1992) . Moreover, although the syndrome widespread experience of physicians treating primary headache syndromes and the neutrophil studies seem of doubtful is almost invariably unilateral, one patient with bilateral pain responded to indomethacin (Pollmann and Pfaffenrath, 1986) .
significance. The pain is excruciating and may be throbbing as it builds up, although it is usually stabbing or boring. In contrast to
Electrophysiological and autonomic studies. In electrophysiological studies, patients with CPH are reported patients with cluster headache some with CPH sit quietly holding their heads or may take to their beds (Stein and to have reduced pain thresholds, reduced corneal reflex thresholds and normal blink reflexes . Rogado, 1980) . This behaviour is rare in cluster headache. The attack frequency ranges from 1 to 40 per day with a Studies of autonomic function, including salivation and nasal secretion did not demonstrate consistent abnormalities median frequency of about 5-10 per day. Patients may have soreness or tenderness in the interval between attacks, (Saunte, 1984) . Facial sweating is normal in CPH (Antonaci, 1991) , although facial sweating abnormalities have been especially if the attacks are frequent. This is not a special feature of CPH but is a generic feature of severe frequent documented in cluster headache (Drummond and Lance, 1992) . Pupillometric studies in CPH demonstrate that the headache which may be expected with the significant nociceptive load being placed on the trigeminal pain system. pupil ipsilateral to the pain is consistently smaller than its unaffected counterpart (Carvalho et al., 1988) , most likely The 2-45 min-duration (Russell, 1984) is shorter than the 15-180 min duration usually accepted for cluster headache reflecting a partial Horner's syndrome. Similar findings were observed in careful studies of patients with cluster headache (Headache Classification Committee of the IHS, 1988), although the overlap can add diagnostic problems. The (Drummond, 1988) . Bradycardia has been observed in CPH and one of five patients studied developed a bundle branch associated autonomic symptoms are almost completely accounted for by cranial parasympathetic activation, as has block and atrial fibrillation during attacks (Russell and Storstein, 1984) . Whether the bradycardia ultimately reflects been documented in cluster headache (Goadsby and Edvinsson, 1994b) save the ptosis which is likely to be a a response to the very severe pain or is part of an underlying autonomic problem requires further study. partial Horner's syndrome due to a functional sympathetic deficit (Drummond, 1985) . Parasympathetic activation may cause oedema of the wall of the internal carotid artery and Blood flow studies. Facial thermographic studies have shown either cold spots over the supraorbital margin or inner subsequent compression of the cervical sympathetic nerves as they pass through the base of the skull. Interestingly, there canthus interictally (Mongini et al., 1990) or increases in temperature over the affected area during the headache are patients with otherwise typical CPH, including a good indomethacin response, with no autonomic features (Bogucki (Drummond, 1985) . The thermographic results of Mongini (Mongini et al., 1990) were identical for patients with CPH et al., 1984; Pareja, 1995b) . Attacks may be precipitated by mechanical stimulation, particularly with head movement and cluster headache. Cerebral blood flow studies of CO 2 reactivity, as measured by transcranial Doppler, were (Sjaastad et al., 1979 (Sjaastad et al., , 1982 in some patients.
abnormal in three patients (Shen, 1993) while ocular blood flow was increased during attacks in a single patient (Horven et al., 1989) . The low numbers of patients in these studies
Pathophysiology and investigations
The essential pathophysiology of CPH is quite unknown. effectively mean that no judgement can usefully be made about the results. However, the modest changes that are seen The comparative rarity of the syndrome as well as the shortlasting nature of the individual attacks make it a difficult are in line with what is reported in regional (Krabbe et al., Table 2 Secondary chronic paroxysmal hemicrania and (Gawel and Rothbart, 1992; Vijayan, 1992) or elsewhere clinical associations (Medina, 1992) . Other structural mimics of CPH include an arteriovenous malformation (Newman et al., 1992b) or Gangliocytoma of the sella turcica (Vijayan, 1992) cavernous sinus meningioma, and secondary CPH is more Collagen vascular disease (Medina, 1992) likely if the patient requires high doses (Ͼ200 mg/day) of Cerebrovascular disease (Newman et al., 1992b) Pancoast tumour (Delreux et al., 1989) indomethacin . Should the pain become
Frontal lobe tumour (Medina, 1992) bilateral then a lumbar puncture should be carried out to
Cavernous sinus meningioma look for intracranial hypertension, even in the face of a Intracranial hypertension; increased CSF pressure (Hannerz and response to indomethacin (Hannerz and Jogestrand, 1993) . Jogestrand, 1993) When appropriate, an electrocardiogram and Holter monitor
Associations: trigeminal neuralgia (CPH-tic syndrome) (Hannerz, 1993) should be considered to look for bundle branch block or cluster headache (Tehindrazanarivelo et al., 1992) atrial fibrillation (Russell and Storstein, 1984) and a chest migraine X-ray should be considered to look for a Pancoast Tumour (Delreux et al., 1989 (Delreux et al., ). 1984 Meyer et al., 1991) or transcranial Doppler studies (Dahl et al., 1990) in cluster headache in which the greater numbers of patients studied make the results more convincing.
Treatment
The standard treatment for CPH is indomethacin in a dose The ocular blood flow changes observed in CPH are similar to those in cluster headache although, in comparison with of 25 mg t.d.s., increasing to 50 mg t.d.s. after a week if there is no response. Occasional patients require higher doses normals, cluster headache patients had relatively reduced flow between attacks (Horven et al., 1989) .
or slow-release indomethacin preparations at night to treat break through headaches. In some patients gastrointestinal side-effects require treatment with gastro-protective agents,
Imaging. MRI studies of patients with CPH have been normal (Antonaci, 1994) , but segmental narrowing of such a histamine-2 or proton pump blockers. There seems to be no tachyphylaxis to the effects of indomethacin (Sjaastad ophthalmic veins on orbital phlebography has been reported (Antonaci, 1994) , similar to the changes seen in cluster and Antonaci, 1987) . Although the IHS criteria require a response to indomethacin, this makes little clinical sense as headache (Hoes et al., 1981; Hannerz, 1988) and in the Tolosa-Hunt syndrome (Tolosa, 1954; Hunt et al., 1961) .
an absolute rule. Certainly other drugs have been reported to favourably affect CPH favourably. Though less effective, The findings on orbital phelbography are neither specific nor likely to be pathophysiologically relevant and the test other non-steroidal anti-inflammatory drugs (NSAIDs), such as naproxen (Hannerz et al., 1987) , have been used. Calciumhas no practical place in patient management.
There are, therefore, no specific diagnostic investigations channel blockers have been reported to be useful in CPH, perhaps analagous to their use in cluster headache. This has for CPH. The only clear conclusion from the pathophysiological and imaging studies of CPH is that attacks are been most convincingly suggested for verapamil (Schlake et al., 1990; Shabbir and McAbee, 1994) . There is a case associated with parasympathetic activation most likely mediated through the greater superficial petrosal outflow report of a patient with an otherwise convincing clinical picture who failed to respond to indomethacin 300 mg t.d.s. with an associated mild partial Horner's syndrome. There is little to suggest a fundamental neurobiological separation but responded to acetazolamide 250 mg t.d.s. (Warner et al., 1994) . Sumatrpitan was reported to be of benefit in a between CPH and cluster headache in regard to the final common pathways activated. The shorter attack duration, patient with bilateral CPH (Hannerz and Jogestrand, 1993) although it was ineffective in a more typical case (Dahlof, greater attack frequency and different effect of indomethacin perhaps points to differences in the generation 1993). In the authors' experience, sumatriptan does not alter CPH in any substantial manner, in contrast to its striking thus central nervous system mechanisms of these disorders. effects in cluster headache (Goadsby, 1994) . This apparent contrast, which may be a reverse of the indomethacin Differential diagnosis. The differential diagnosis of CPH includes the other primary short-lasting headaches (Table 1) response, must be regarded as preliminary until there are sufficient reports of longer duration CPH that do not respond and the secondary causes of CPH (Table 2) . Because secondary CPH is relatively common, investigations are to sumatriptan. The lack of a response in very short headaches may be simply that, even in cluster headache, the response required to identify or exclude treatable underlying causes. A reasonably complete screening of a patient with CPH, takes 7-10 min (Ekbom, 1991) . It would be of great interest to treat a longer CPH attack with oxygen, which is certainly considering the associated clinical problems reported, would include a blood count, looking for thrombocythaemia effective in cluster headache (Kudrow, 1981) . The acute attack response should be contrasted with preventative treatment in (MacMillan and Nukada, 1989) , ESR (erythrocyte sedimentation rate) and vasculitic investigations (Medina, 1992) , cluster headache and CPH. The only consistent picture for a preventative in the literature is that verapamil is effective for and a brain imaging procedure looking for an intracranial tumour such as a lesion in the region of the sella turcica both CPH and cluster headache.
form ends of a spectrum. The clinical cases of transformation
Episodic paroxysmal hemicrania (EPH)
from the episodic to the chronic phase are perhaps the clearest EPH is an extremely rare form of headache characterized by evidence that EPH and CPH are closely biologically related. frequent, daily attacks of short-lived, unilateral very severe However, following the analogy of cluster headache we headache with accompanying ipsilateral autonomic features prefer a nosology which distinguishs the two. (Kudrow et al., 1987; Newman et al., 1992a; Spierings, 1992) . Periods of frequent attacks are separated by relatively long remissions lasting weeks or months in a pattern similar to episodic cluster headache (Headache Classification
Short-lasting unilateral neuralgiform headache
Committee of the IHS, 1988). Named by Kudrow (Kudrow with conjunctival injection and tearing et al., 1987) some consider this headache an episodic variant (SUNCT) of CPH (Newman et al., 1992a) 
but definitive classification
This form of short-lasting headache is also among the rarest will require more data. A new case of one the author's of headache syndromes and again has curious autonomic (P.J.G.) will serve to describe this condition.
associations . Several clinical features differentiate it from other short-lasting headaches. A new
Case report. A 35-year-old woman presented with an case of one of the author's (P.J.G.) will illustrate the 8-year history of headache. She described stabbing severe clinical picture. left frontal and retro-orbital pains that would last 1-2 min and occur 3-5 times per day. The attacks were associated with marked watering of the left eye and left sided ptosis.
Case report
She had no nasal stuffiness nor migrainous features. She
A 56-year-old woman presented with a 5-year history of would typically move rather than be still during an attack.
daily episodic short-lasting headaches. Attacks occurred up The attacks came in bouts of 6 months with intervening to five times a day and lasted 15-20 s each. The attacks breaks of 10-12 months. She had been tried on numerous were left-sided, moderately severe and retro-orbital. They medications, including, corticosteroids, methysergide, lithium, were associated with marked tearing and redness of the propranolol, pizotifen and amitriptyline, and had used ipsilateral eye with mild rhinorrhoea. There was no nausea, ergotamine. All of these had been without effect. When she photophobia or phonophobia. There was no history of was first seen by the author she was 2 months into a bout.
migraine nor family history of headache. On examination, She was commenced on indomethacin 25 mg t.d.s. and her here were no physical signs of the nervous system and headaches ceased completely after 3 days. The drug was she was normotensive. MRI of the brain was normal. She stopped 2 weeks later and the attacks recurred within 2 days, had used amitriptyline, propranolol, pizotifen, methysergide, they again settled rapidly when indomethacin was restarted. lithium and verapamil without success. The latter made the attacks longer and the pain more severe. She had had a trial of steroids and used ergots and sumatriptan without success. She also had an unsuccessful trial of indomethacin, valproate
Clinical features
and carbamazepine. She was refractory when lost to There are 13 cases of EPH in the literature (Geaney, 1983;  follow-up. Bogucki and Niewodniczy, 1984; Kudrow et al., 1987; Spierings, 1988; Blau and Engel, 1990; Alberca et al., 1991; Newman et al., 1992a) . The headache consists of bouts of short-lasting headache varying from 1 to 30 min which have
The patients recognized with this problem are largely males been reported to occur from six to 30 times a day. The pain is described as severe, throbbing or stabbing and is localized with a gender ratio of 17 to 2 (Pareja and Sjaastad, 1994) . The paroxysms of pain usually last between 5 and 250 s to the orbital or temporal regions. There is no evidence for a sex-based predominance and the age of onset varies from (Pareja et al., 1996b) although longer duller interictal pains have been recognized, as have attacks up to 2 h in two 12 to 51 years. All published reports, and this author's (P.J.G.) single case experience, have an absolute response to patients (Pareja et al., 1996a) . Patients may have up to 30 episodes per hour although more usually they would have indomethacin. Calcium-channel blockers have also been used (Coria et al., 1992) . The author has used naproxen in a single 5-6 per hour. The frequency may also vary in bouts. A frequency as low as once or twice in 1-4 weeks has been patient and the response was incomplete compared with indomethacin. Further reports are required to describe the seen in a male patient who at other times had up to 20 attacks a day (Sjaastad et al., 1991) , while another reported condition more clearly with respect to its natural history and relationship to cluster headache and CPH. It is well recognized case had almost continuous attacks for up to 3 h (Pareja et al., 1994) . A systematic study of attack frequency (see above) that EPH may evolve from a disorder with distinct intervals into a chronic unremitting form which is demonstrated a mean of 28 attacks per day with a range of 6-77 (Pareja et al., 1996b) . The conjunctival injection identical to CPH. It is likely that the two conditions are ends of a spectrum just as episodic and chronic cluster headache seen with SUNCT is often the most prominent autonomic cluster headache (Cremer et al., 1995) . trigeminal system proper are well documented in the laboratory (Kaube et al., 1993) 
and in clinical practice
This summary is drawn from a recent excellent review (Pareja et al., 1995) and the authors' personal experience. -ϭ treatment (Martins et al., 1993) . Just as there is a reported case of CPH had no effect; X ϭ treatment worsened condition; s.c. ϭ a SUNCT syndrome (Bouhassira et al., 1994) . These cases suggest that the trigeminal pathways may be involved in the entire range of short-lasting headache syndromes. cause. Transcranial Doppler and SPECT (single photon emission computed tomography) studies have not demonstrated convincing change in the vasomotor activity (Shen and Johnsen, 1994) or cerebral blood flow during attacks of
Investigations
Orbital phlebography is reported to be abnormal in SUNCT pain (Poughias and Aasly, 1995) . with a narrowed superior ophthalmic vein homolateral to the pain . This finding leads to the suggestion that SUNCT may be a form of orbital venous vasculitis
Treatment of SUNCT
Unlike CPH and EPH, which are highly responsive to (Hannerz et al., 1992) , although their are similar reports in cluster headache, Tolosa-Hunt syndrome and in CPH (see indomethacin, SUNCT is remarkably refractory to all treatments so far described, including indomethacin (Table  above) . Forehead sweating is usually increased during bouts unlike CPH in which it is normal.
3). Most drugs used in the treatment of other short-lasting headaches are not useful in SUNCT. Indeed it is the authors' Pupillary studies using pupillometry and pharmacological approaches have revealed no abnormalities (Zhao and experience, and well recognized in published series (Pareja et al., 1995) , that SUNCT can be very refractory to therapy. Sjaastad, 1993) . Since conjunctival injection occurs during SUNCT, it is not surprising that intraocular pressure and Drugs and procedures that have been reported to be either useful or without effect in SUNCT are recorded in Table 3 . corneal temperatures are elevated during attacks . This most likely reflects marked parasympathetic A recent report (Ghose, 1995) cites two patients with a provisional diagnosis of SUNCT which responded to activation with local vasodilatation. Similarly, a report of bradycardia in association with attacks of SUNCT may sumatriptan. These are most likely to represent a spontaneous remission and are only described in a limited way. similarly indicate increased parasympathetic outflow . Systolic blood pressure is someIndomethacin is not generally useful in SUNCT. times elevated (Kruszewski et al., 1991) , although ventilatory function is normal (Kruszewski et al., 1995) . The parasympathetic manifestations favour a central pathogenesis
Hemicrania continua (HC)
As its name implies, HC is characterized by a continuous, for SUNCT as a manifestation of the trigeminovascular reflex , rather than a peripheral vasculitic unilateral headache pain which is usually of moderate severity (Sjaastad and Spierings, 1984) . Three-fifths of patients have form (32%); and unremitting form (53%). Not surprisingly, a chronic form evolving to a remitting form (Pareja, 1995a) , superimposed attacks of more intense pains which are often short-lived but may last up to several days. The painful a bilateral case (Pasquier et al., 1987) and a patient whose attacks alternated sides (Newman et al., 1992c) have all exacerbations are often associated with autonomic features, including ptosis, conjunctival injection, lacrimation and been described. Like the short-lived trigeminal autonomic cephalgias, HC is characterized by episodic attacks of head nasal congestion, hence the inclusion of this headache syndrome in this review. In general, these features are less pain associated with ipsilateral autonomic features. Like the paroxsymal hemicranias, HC is uniquely responsive to prominent than the autonomic features of cluster headache or of the paroxysmal hemicranias. An unpublished case of indomethacin although a series of four patients who did not respond, but fit the clinical phenotype, have been described one of the author's (R.B.L.) will illustrate the clinical features.
( Kuritzky, 1992) . A case responding to piroxicam-β-cyclodextrin (Trucco et al., 1992) further suggests that while the NSAID response is of great interest, it points to rather than
Case report
A 45-year-old woman presented with a 10-year history of expresses the pathophysiology. HC is differentiated from the other trigeminal autonomic daily unilateral headache. In the remote past, she had occasional periods of left-sided headache lasting from cephalgias primarily by its continuous moderate pain without autonomic features between the painful exacerbations. 1 month to 1 year. At the time of presentation, she had a constant, widely distributed, left-sided hemicranial headAlthough there are no reports of secondary HC, a C7 root irritation due to a disc herniation has been noted to aggravate ache which waxed and waned in severity. The pain was usually mild to moderate but from eight to 20 times a month the condition . A case of a mesenchymal tumour in the sphenoid bone has also been reported in which she experienced exacerbations which lasted up to 12 h, characterized by more severe left periorbital and hemicranial the response to indomethacin faded after 2 months . These cases suggest that escalating pain accompanied by left-sided miosis, ptosis and nasal congestion. The exacerbations were also associated with doses or loss of efficacy of indomethacin should be treated with suspicion and the patient re-evaluated. The condition is nausea and sensitivity to sensory stimuli. Her past medical history was unremarkable. General medical and neurological seen in non-caucasian populations (Joubert, 1991) . examinations and routine laboratory studies were unremarkable. MRI of the head was normal in the past.
She had been treated with several beta-blockers, calcium-
Pathophysiological studies
channel blockers, tricylic antidepressants, serotonin re-uptake The relative rarity of HC has also made it difficult to study inhibitors, methysergide and divalproex sodium, without its pathophysiology. It is reported that pain pressure thresholds relief. Inpatient treatment with dihydroergotamine did not are reduced in patients with HC as they are in CPH (Antonaci improve her headaches. Acute treatment with several et al., 1994) . In contrast, orbital phlebography is relatively NSAIDs, transnasal butorphanol and bultalbutal combinanormal compared with that in patients with CPH (Antonaci, tion products were not helpful. Subcutaneous sumatriptan 1994), although it should be observed that this area is produced short-term relief during painful exacerbations.
controversial (Bovim et al., 1992) . Pupillometric studies have Following a tentative diagnosis of HC, she was started on shown no clear abnormality in HC indomethacin 50 mg t.d.s. a day. Her daily headache resolved and studies of facial sweating have shown modest changes following each dose but recurred at the end of dosing similar to those seen in CPH (Antonaci, 1991) . intervals. Her regimen was gradually increased to a final dose of 75 mg t.d.s. daily with ranitidine (150 mg b.d.). Her other medications have been tapered and she is headache free unless she skips a dose of indomethacin.
Classification
The nosology of these headaches is a difficult issue. While they are clearly daily or near daily by definition and have thus been sensibly listed with other headache syndromes that Newman et al. (1994) have classified patients with HC into cause daily headache (Silberstein et al., 1994) . Medication overuse, a common aggravating factor in headache syndromes three groups: (i) those with a remitting form with distinct headache phases lasting weeks to months with prolonged (Mathew, 1987; Sheftell, 1992) , may confuse the diagnosis of HC (Young and Silberstein, 1993) . Whether medication pain free remissions (Iordanidis and Pareja et al., 1990) ; (ii) those with an evolutive unremitting form overuse can produce HC is not settled. Given the overlap with the other trigeminal-autonomic cephalgias, we propose which arises from the remitting form (Sjaastad and Tjorstad, 1987; Sjaastad and Antonaci, 1993) ; and (iii) those with an that HC be classified for the moment with those headaches. It is likely that the indomethacin response that is shared unremitting form characterized by continuous headache from the onset (Zukerman et al., 1987) . The proportion of patients between the paroxysmal hemicranias and HC will have some clear linked pharmacological basis and further suggests that in each group is as follows: remitting form (15%); evolutive a convenient classification of these headaches together may A point of diagnostic difficulty may arise with the clustertic syndrome (Solomon et al., 1985; Watson and Evans, eventually have some biological basis. 1985) . This syndrome is characterized by the combination of idiopathic trigeminal neuralgia and cluster headache. The pain of trigeminal neuralgia is lancinating, lasts for seconds,
Clinical features

Hypnic headache
and is more common in the second and third divisions of the Hypnic headache is a rare short-lived primary headache trigeminal nerve. It is often triggered by facial or buccal disorder. Although it should be considered in the differential stimulation in the form of chewing, brushing teeth or touching diagnosis of trigeminal autonomic cephalgias it is defined, the face. The cluster headache component spans the range in part, by the paucity of autonomic features. A case history of typical cluster headache, attacks lasting 45 min with will illustrate its main features.
autonomic features such as lacrimation and nasal blocking, through to shorter attacks of 30 s at a frequency of 40 per day, more suggestive of a paroxysmal hemicrania (Alberca
Case history
and Ochoa, 1994). Carbamazepine may be useful in these An 84-year-old woman presented with a 2-year history of patients as it is in trigeminal neuralgia. Given the report of nocturnal headaches. The headache awakened her from sleep, the CPH-tic syndrome (Hannerz, 1993 ) which responded to usually three times a night, at~2 h intervals. The headaches indomethacin, it seems possible that various TACs may be were diffuse in location and of pulsating quality, lasting associated with trigeminal neuralgia. To determine whether 30 min. There were no autonomic features. Specifically this is a distinct pathophysiological entity (Alberca and ptosis, lacrimation and rhinorrhoea were absent. The headOchoa, 1994) or the coincidental overlap of two entities, aches never occurred during the day. Treatment with antifurther study will be required (Solomon et al., 1985 ; Watson depressants and sedative hypnotics had no effect. Her general and Evans, 1985) . At this time we suggest that the disorder medical and neurological examination, routine laboratory is classified under the TACs in a miscellaneous section until studies and a CT of the head were unremarkable. Treatment more data are available. Lastly, one is sometimes left with with lithium carbonate 600 mg at bedtime resulted in a patients who have short-lasting pains not associated with sustained remission of her headaches.
autonomic features that are longer than a conventional Of the eight reported cases with hypnic headache reviewed stab. Such a patient may have episodic pains lasting 2-3 min by Newman et al. (1990) , all had recurrent attacks of that are severe, triggerable and responsive to carbamazepine generalized headache which awakened them at a consistent (Mulleners and Verhagen, 1996) . We would consider these time each night. The disorder enters into the differential part of the spectrum of trigeminal neuralgia. diagnosis of trigeminal autonomic cephalgias because of While all of the TAC disorders may involve trigeminalthe short-lived nature of the attacks and is differentiated by autonomic activation, the mechanisms which account for the the lack of autonomic features. differences in clinical profile and treatment response are unknown. There are simply insufficient data to answer these questions at the moment although it must be said, based on
Clinical features and differential diagnosis of
available data, that these headaches have more similarities trigeminal-autonomic cephalgias (TACs) and than differences.
related disorders
The TACs are characterized by short-lasting headaches with autonomic features. For CPH, EPH and the SUNCT
Pathophysiology of TACs
We propose that the trigeminal-autonomic reflex can account syndrome, autonomic features accompany attacks of severe pain. In HC the autonomic features rarely present when the for many of the features of cluster headache, CPH, EPH and SUNCT as well as the painful exacerbations of HC. This pain is mild and become more prominent during severe pain. Pain and autonomic features may be dissociated, as reflex pathway consists of a brainstem connection between the trigeminal nerve and facial (VIIth cranial nerve) parathey may be in CPH (Pareja, 1995b) . Hypnic headache attacks are short-lived, moderate in intensity and not accomsympathetic outflow. It has been clearly shown in animal studies that stimulation of the trigeminal ganglion results in panied by autonomic features. Thus, severe short-lived pain is the usual concomitant of autonomic features. Despite their increased extracerebral (Goadsby et al., 1986) and cerebral blood flow (Goadsby and Duckworth, 1987) . For both the common elements, the TACs differ in attack duration and frequency as well as the response to therapy (Table 4) . Of extracerebral (Lambert et al., 1984) and the cerebral components (Goadsby and Duckworth, 1987) , the major part the disorders discussed herein, the SUNCT syndrome has the shortest attack duration and the highest attack frequency.
of the vasodilator response is mediated via a reflex connection with the facial (VIIth cranial) nerve, the cranial paraThe paroxysmal hemicranias have intermediate durations (1-45 min) and intermediate attacks frequencies. Cluster sympathetic outflow (Goadsby, 1989) . Stimulation of the trigeminal ganglion leads to local release of trigeminal (CGRP headache has longer attack durations (15-180 min) and relatively low attack frequencies.
and substance P) and parasympathetic (VIP) marker peptides 
*Characteristically elderly patients aged 67-84 years (Newman et al., 1990) responding to lithium (Raskin, 1988) . † May have exacerbations (see text). V1/2/ 3 ϭ ophthalmic/maxillary/mandibular divisions of the trigeminal innervation; ϩ ϭ effective; Ϯ ϭ effect not consistent; -ϭ not effective.
in cats (Goadsby and Edvinsson, 1994a) and humans mediated changes in facial temperature or facial flushing respect the trigeminal somatotopic cutaneous innervation. . Moreover, trigeminal ganglion stimulation also leads to cerebral vasodilatation in humans Perhaps the trigemino-autonomic reflex follows a similar spatial pattern. Our most recent laboratory evidence suggests (Tran-Dinh et al., 1992) . The trigeminal afferent arm of this reflex is clearly active in migraine  that intracranial pain-sensitive structures are indeed more potent at eliciting cerebral than non-cerebral changes in Goadsby and Edvinsson, 1993; Gallai et al., 1995) while the parasympathetic arm is active in cluster headache (Fig. 1) cranial blood flow when stimulated (Goadsby et al., 1995) . However, in both CPH and cluster pain, autonomic features (Goadsby and Edvinsson, 1994b; Fanciullacci et al., 1995) . A single patient with CPH had and pain are sometimes dissociated. This dissociation requires either independent activation of trigeminal and paraelevated CGRP and VIP during a period of frequent severe attacks. The CGRP level rose from a control of 41 pmol/l sympathetic pathways or differential modulation of their activity. At a biological level we would predict that, in animal while on indomethacin to a maximum of 123 pmol/l during pain. Similarly, the VIP level was 7 pmol/l on indomethacin models, changes in markers of trigeminal activation (i.e. CGRP) should predict changes in parasympathetic markers rising to 32p mol/l during an attack. These data are illustrated in Fig. 2 and compared with changes in migraine, which are (i.e. VIP), which is what has been reported (Zagami et al., 1990) . less marked, and changes in cluster headache, which are similar. Based on these data, we believe that the the trigemino-A clinical challenge to the model arises from the variation in patterns of autonomic symptoms from syndrome to synfacial reflex is a key part of the pathophysiological expression of these syndromes. This anatomy links the clinical problems drome. For example, conjunctival injection is usually quite prominent in SUNCT. There is also variation from individual and suggests that these syndromes should broadly be classified together.
to individual, just as in cluster headache patients lacrimation may be more prominent than nasal congestion and vice versa. Experimental studies must seek the anatomical or functional basis for such variation.
Issues surrounding the pathophysiology of TACs
If the biological model is correct, it should explain the The triggering mechanism from the neck must be explained. Are there brainstem connections that again reflexly connect available clinical and biological data and generate testable predictions. We postulated that trigeminal activation leads to with the autonomic efferents? Is such activation prior to, or following, the activation of the second order trigeminal reflex autonomic activation. At a clinical level, we would predict that there should be a pain threshold above which neurons? Lastly, what of indomethacin? What is so special in regard to the pharmacology of this NSAID? There is an autonomic symptoms occur, modified by the highly somatotopic and functionally organized central connections of the old observation that indomethacin can alter the cerebral hypercapnic vasodilator response (Pickard et al., 1977) which trigeminovascular system. This roughly corresponds to the clinical observation of autonomic features during painful has a permissive component that involves generation of NO (nitric oxide) (Iadecola, 1992) . Similarly, the facial (VIIth exacerbations of HC. It has been shown experimentally in cats (Lambert et al., 1984) and in humans (Goadsby et al., nerve) cranial parasympathetic outflow ganglia, sphenopalatine and otic ganglia contain NO synthase, and NO 1988) that, during trigeminal thermocoagulation, trigeminally Fig. 1 Drawing of the anatomy of the trigemino-autonomic cephalgias. Both dura mater and large blood vessels are innervated largely by CGRP nerves that arise in the trigeminal ganglion. These bipolar nerves synapse in the trigeminal nucleus caudalis (Vn) including its caudal extension into the C 1 and C 2 dorsal horns of the cervical spinal cord. Pain signals are then transmitted via second order neurons to the thalamus and then to the cortex for appreciation as pain. There is a functional connection to the premotor parasympathetic neurons of the VIIth cranial (facial) nerve located in the superior salivatory nucleus (SSN). These neurons in turn give rise to preganglionic fibres that pass through the geniculate ganglion and synapse in the pterygopalatine (illustrated) and otic ganglia. Ganglionic transmission is by way of acetylcholine activating a nicotinic receptor. Postganglionic fibres transverse the greater superficial petrosal to innervate both the cranial vessels and provide parasympathetic autonomic innervation to structures, such as the lacrimal glands and nasal mucosa, accounting for the marked parasympathetic autonomic features seen in these headaches. Fig. 2 The figure demonstrates the changes in (A) calcitonin gene-related peptide (CGRP) and (B) vasoactive intestinal polypeptide (VIP) in cranial venous blood during attacks of migraine (with and without aura), cluster headache and chronic paroxysmal hemicrania (CPH). The level of elevation of CGRP and VIP in the CPH patient is comparable with that seen in cluster headache patients (Goadsby and Edvinsson, 1994b; Fanciullacci et al., 1995) . (Table 6) A. At least 30 attacks fulfilling B-E 3.2.1 Episodic paroxysmal hemicrania B. Attacks of severe unilateral orbital, supraorbital and/or 3.2.2 Chronic paroxsymal hemicrania temporal pain always on the same side lasting 2-45 min 3.3 Shortlasting neuralgiform headache with conjunctival injection C. Attack frequency above 5 a day for more than half the time and tearing (Table 7) (periods with lower frequency may occur) 3.4 Hemicrania continua (Table 8) D. Pain is associated with at least one of the following signs/ symptoms on the pain side: 1. Conjunctival injection generation is involved in the vasodilator responses of this 2. Lacrimation 3. Nasal congestion system . Further experiments are 4. Rhinorrhea required to determine whether indomethacin attenuates the 5. Ptosis facial nerve cranial parasympathetic outflow directly.
6. Eyelid oedema E. At least one of the following:
1. There is no suggestion of one of the disorders listed in groups 5-11.
TACs and their classification
2. Such a disorder is suggested but excluded by appropriate A headache classification system should be reliable, valid, investigations.
comprehensive and generalizable (Lipton et al., 1993) . is not comprehensive in that it excludes a number of (usually in doses of 150 mg/day or less) increasingly recognized primary headache disorders. These
Episodic Paroxysmal Hemicrania
exclusions are partially historical and we consider that some classification. Such a re-classification is summarized in Table   E . Pain is associated with at least one of the following signs or similarities are hardly surprising. The syndromes will be better studied separately until their pathophysiology is underNote: In most cases responds rapidly and absolutely to stood and the common mechanisms elucidated. The rarity of indomethacin (usually 150 mg/day or less).
the headaches discussed has severely limited their study and acknowledgement. The criteria for episodic and chronic cluster headache are methacin but this definition precludes diagnosis prior to a therapeutic trial or results in reclassification of patients unchanged. We present criteria for paroxysmal hemicranias, analagous to the structure of the cluster headache criteria who fail to respond to treatment. It is our view that the indomethacin response should be a confirmatory criteria, not (Table 6 ) as has been suggested . The most problematic aspect of the case definition is the role of an absolute requirement. SUNCT has been included within the classification of indomethacin responsiveness in defining the disorder. Virtually every case responds promptly to treatment with indoTACs. The criteria presented in Table 7 permit the classifica- (SUNCT) 
